TY - JOUR
T1 - Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas
AU - Virmani, Arvind K.
AU - Rathi, Asha
AU - Zöchbauer-Müller, Sabine
AU - Sacchi, Nicoletta
AU - Fukuyama, Yasuro
AU - Bryant, David
AU - Maitra, Anirban
AU - Heda, Shashank
AU - Fong, Kwun M.
AU - Thunnissen, Frederik
AU - Minna, John D.
AU - Gazdar, Adi F.
PY - 2000/8/16
Y1 - 2000/8/16
N2 - Background: Retinoic acid plays an important role in lung development and differentiation, acting primarily via nuclear receptors encoded by the retinoic acid receptor-β (RARβ) gene. Because receptor isoforms RARβ2 and RARβ4 are repressed in human lung cancers, we investigated whether methylation of their promoter, P2, might lead to silencing of the RARβ gene in human lung tumors and cell lines. Methods: Methylation of the P2 promoter from small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) cell lines and tumor samples was analyzed by the methylation-specific polymerase chain reaction (PCR). Expression of RARβ2 and RARβ4 was analyzed by reverse transcription-PCR. Loss of heterozygosity (LOH) was analyzed by PCR amplification followed by electrophoretic separation of PCR products. Statistical differences were analyzed by Fisher's exact test with continuity correction. Results: The P2 promoter was methylated in 72% (63 of 87) of SCLC and in 41% (52 of 127) of NSCLC tumors and cell lines, and the difference was statistically significant (two-sided P
AB - Background: Retinoic acid plays an important role in lung development and differentiation, acting primarily via nuclear receptors encoded by the retinoic acid receptor-β (RARβ) gene. Because receptor isoforms RARβ2 and RARβ4 are repressed in human lung cancers, we investigated whether methylation of their promoter, P2, might lead to silencing of the RARβ gene in human lung tumors and cell lines. Methods: Methylation of the P2 promoter from small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) cell lines and tumor samples was analyzed by the methylation-specific polymerase chain reaction (PCR). Expression of RARβ2 and RARβ4 was analyzed by reverse transcription-PCR. Loss of heterozygosity (LOH) was analyzed by PCR amplification followed by electrophoretic separation of PCR products. Statistical differences were analyzed by Fisher's exact test with continuity correction. Results: The P2 promoter was methylated in 72% (63 of 87) of SCLC and in 41% (52 of 127) of NSCLC tumors and cell lines, and the difference was statistically significant (two-sided P
UR - http://www.scopus.com/inward/record.url?scp=0034674916&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034674916&partnerID=8YFLogxK
M3 - Article
C2 - 10944551
AN - SCOPUS:0034674916
SN - 0027-8874
VL - 92
SP - 1303
EP - 1307
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 16
ER -